Optimizing Spravato Prior Authorization for Orthopedics

The Interplay of Treatment-Resistant Depression and Orthopedic Care

Orthopedic patients often present with complex health profiles, including co-morbid mental health conditions such as treatment-resistant depression. When a patient undergoing orthopedic treatment requires Spravato, the orthopedic practice may be involved in coordinating care or managing associated prior authorization documentation within their EMR system. This intersection necessitates robust processes to ensure seamless patient care without compromising orthopedic treatment schedules.

Spravato Prior Authorization Fundamentals

Spravato (esketamine) is a high-volume prior authorization target across commercial, Medicare Advantage, and Medicaid managed care plans due to its specific indications and administration requirements. Approval typically hinges on documenting a confirmed diagnosis of TRD, evidence of failed trials of at least two other oral antidepressant medications, and a treatment plan outlining administration in a certified healthcare setting. Understanding these core requirements is critical for any practice involved in the patient's overall care continuum.

Documentation for Spravato PA in an Orthopedic Context

• **Diagnosis Confirmation:** Clear documentation of a TRD diagnosis, often supported by psychiatric evaluation.
• **Failed Prior Therapies:** Evidence of at least two failed trials of oral antidepressants, including dosages and duration.
• **Treatment Plan:** Proposed Spravato dosing regimen and confirmation of administration in a certified facility.
• **Co-morbidity Impact:** Documentation linking the patient's mental health status to their orthopedic condition or recovery, if relevant for care coordination.
• **Coordination of Care:** Records of communication and collaboration with mental health providers overseeing Spravato treatment.

Common Prior Authorization Denials for Spravato

Denials for Spravato prior authorization most frequently stem from insufficient documentation of prior failed therapies or a lack of clear medical necessity for TRD. In an orthopedic setting, mismanaged Spravato PA can indirectly impact surgical scheduling or advanced imaging approvals if delays in overall patient care coordination occur. Other common denial reasons include issues with the proposed treatment setting or insufficient clinical justification for continued therapy.

Klivira's Approach to Co-Morbid PA Management in Orthopedics

Klivira's platform is designed to manage the complexities of prior authorization for patients with intersecting medical needs. For orthopedic practices, this means our system can help orchestrate multi-step PA cascades, from advanced imaging to surgical procedures, while also accommodating the documentation requirements for co-morbid conditions like TRD. By integrating with EMRs and payer portals, Klivira automates data retrieval and submission, reducing manual burden and potential delays.

Streamlining Orthopedic PA Workflows with Klivira

• **AAOS-Guideline-Aware Logic:** Tracks conservative-care trial duration and modalities for orthopedic procedures.
• **Imaging-Vendor Routing:** Identifies and routes advanced imaging requests to appropriate specialty benefit-management vendors.
• **Multi-Step PA Orchestration:** Manages sequential PAs for imaging, surgery, and post-operative DME.
• **BMI and Imaging Documentation:** Automates retrieval of vitals, problem lists, and imaging history from EMRs for criteria-based approvals.
• **Peer-to-Peer Scheduling Integration:** Facilitates scheduling and documentation for clinical-necessity denial reviews.